TP53 mutations predict for poor survival in de novo diffuse large B-cell lymphoma of germinal center subtype

Leukemia Research
Norafiza ZainuddinGunilla Enblad

Abstract

Presence of TP53 mutations has been associated with poor prognosis in diffuse large B-cell lymphoma (DLBCL), although this has remained controversial. The TP53 codon 72 polymorphism has shown negative impact on cancer survival, but this has not been analyzed in DLBCL. Furthermore, the MDM2 SNP309 has been associated with earlier age of onset in DLBCL. Here, we investigated the clinical impact of TP53 mutations, MDM2 SNP309 and TP53 codon 72 polymorphisms on survival in DLBCL of germinal center (GC) and non-GC subtypes. Thirteen of the 102 (12.7%) patients displayed TP53 mutations. Overall, TP53 mutations had a significant effect on lymphoma-specific survival (LSS, P=0.009) and progression-free survival (PFS, P=0.028). In particular, inferior survival was observed in TP53-mutated DLBCLs of GC subtype (LSS, P=0.002 and PFS, P=0.006). Neither MDM2 SNP309 nor the TP53 codon 72 polymorphism had an impact on age of onset or survival. Altogether, our data suggests that TP53 mutations are associated with poor outcome in GC-DLBCL patients.

References

Jul 5, 1991·Science·M HollsteinC C Harris
Mar 1, 1995·Cancer Metastasis Reviews·M B KastanC J Leonard
Aug 21, 1997·The New England Journal of Medicine·A IchikawaT Hotta
Jan 15, 2000·Mutation Research·M HollsteinP Hainaut
Jun 21, 2002·The New England Journal of Medicine·Andreas RosenwaldUNKNOWN Lymphoma/Leukemia Molecular Profiling Project
Aug 15, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K LeroyUNKNOWN Groupe d'Etude des Lymphomes de l'Adulte
Mar 6, 2003·Human Mutation·Christophe Béroud, Thierry Soussi
Nov 26, 2003·International Journal of Cancer. Journal International Du Cancer·David Pim, Lawrence Banks
Feb 22, 2005·Current Cancer Drug Targets·Zhuo Zhang, Ruiwen Zhang
May 28, 2005·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Mattias BerglundGunilla Enblad
Jul 22, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Johanna TommiskaHeli Nevanlinna
Sep 22, 2005·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·B SaffariM F Press
Nov 10, 2005·Human Mutation·Dalil HamrounThierry Soussi
Feb 16, 2006·Journal of the National Cancer Institute·Chiara MeninRoberta Bertorelle
Feb 24, 2006·International Journal of Cancer. Journal International Du Cancer·Helge LindAage Haugen
Jul 5, 2006·Journal of the National Cancer Institute·Brenda J BoersmaStefan Ambs
Sep 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Naoki OhmiyaHidemi Goto
Jun 1, 2007·Breast Cancer Research : BCR·Tatsuya ToyamaYoshitaka Fujii
Jun 5, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Marta Sanchez-CarbayoCarlos Cordon-Cardo
Jul 20, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hiroshi HirataRajvir Dahiya

❮ Previous
Next ❯

Citations

Oct 9, 2012·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Lena CederbladNongnit Laytragoon-Lewin
Mar 10, 2010·Biochemistry. Biokhimii︠a︡·A V SorokinL P Ovchinnikov
Jan 20, 2011·Cancer Informatics·Xuesong HanShuangge Ma
Nov 18, 2015·Annals of Hematology·Elena SebastiánMarcos González
Oct 26, 2010·International Journal of Radiation Oncology, Biology, Physics·Gérard GanemPhilippe Solal-Celigny
Sep 28, 2010·Leukemia Research·Norafiza ZainuddinRichard Rosenquist
Jun 4, 2014·European Journal of Haematology·Gustav HedströmMattias Berglund
Jul 18, 2017·Expert Review of Hematology·Alice Di RoccoMaurizio Martelli
Aug 28, 2018·Hematological Oncology·Patrizia CiammellaAndrea Riccardo Filippi
Aug 3, 2021·Critical Reviews in Oncology/hematology·Maria Lopez-SantillanIdoia Martin-Guerrero

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis